Form 4 for OMCL OMNICELL, INC.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001928727-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | 2026-03-16 | OMCL | Manley Corey J | EVP, CHIEF LEGAL, ADMIN Off | S - Sale | $34.69 | -7,405 | 96.7K | -7% | -$256.9K | |
| 2026-03-17 | 2026-03-15 | OMCL | Manley Corey J | EVP, CHIEF LEGAL, ADMIN Off | F - Tax | $34.40 | -3,819 | 104.1K | -4% | -$131.4K | |
| 2026-03-17 | 2026-03-15 | OMCL | Manley Corey J | EVP, CHIEF LEGAL, ADMIN Off | A - Grant | $0.00 | +22.4K | 107.9K | +26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-16 | S | D | 7,405 | $34.69 | 96,717.34 | D | — | — | (F3) This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025. (F4) The price reported in Column 4 is an exact price of $34.69 for all shares sold. |
| 2 | Common | Common Stock | 2026-03-15 | F | D | 3,819 | $34.40 | 104,122.34 | D | — | — | (F2) Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. |
| 3 | Common | Common Stock | 2026-03-15 | A | A | 22,445 | $0.00 | 107,941.34 | D | — | — | (F1) Reflects performance-based restricted stock units that were previously granted on March 15, 2025, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 5, 2026 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 22,445 performance-based restricted stock units (100% of target) of which 25% vested upon the one year anniversary of the grant date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively). |